Sid Sijbrandij is the co-founder of GitLab, one of the world’s largest open-source software companies. But in 2022, his life took a radical turn — he was diagnosed with a rare and aggressive form of cancer.

Instead of relying solely on the medical system, Sid took a different approach. He ran every diagnostic imaginable, developed experimental treatments, combined therapies, and ultimately built his own path to survival — even when doctors ran out of options.

In this episode, we explore how Sid applied first-principles thinking to medicine, why healthcare systems are fundamentally misaligned with patient incentives, and what the future of personalized treatments could look like.

Yaron Brook, chairman of the Ayn Rand Institute and host of the Yaron Brook Show, joins Niklas to discuss the moral and philosophical foundations of capitalism.

They explore Ayn Rand’s philosophy of Objectivism, the ethical case for individual freedom, and why capitalism is often misunderstood in modern political discourse. The conversation also touches on libertarian governance, free private cities, and what a truly free society could look like in practice.

A deep dive into capitalism, philosophy, and the future of human freedom.

In this episode, he and Niklas explore how genome sequencing, DNA synthesis, and CRISPR are turning life into an engineering platform. From coding proteins and viruses to writing entire genomes, Andrew explains how biotech is moving from reading DNA to actively programming it.

They discuss N-of-1 personalized therapies, biosecurity in an age of cheap DNA synthesis, and why open science could accelerate biotech innovation. The conversation also touches on cloning, embryo editing, and the long-term future of human enhancement.

Topics include:

· DNA as digital code · Genome writing and synthetic cells · CRISPR and programmable biology · Personalized genetic medicine · Biosecurity and engineered viruses · Open biotech vs. proprietary models · Cloning and human genome design

A conversation for builders, founders, and technologists thinking about biology as the next software layer.